CorMedix (CRMD) Accounts Payables (2010 - 2025)

CorMedix (CRMD) has 15 years of Accounts Payables data on file, last reported at $7.9 million in Q4 2025.

• For the quarter ending Q4 2025, Accounts Payables rose 358.37% year-over-year to $7.9 million; the trailing twelve-month figure through Dec 2025 stood at $7.9 million (up 358.37% YoY), and the FY2025 full-year result was $7.9 million, up 358.37% from the prior year.
• Accounts Payables retreated to $7.9 million in Q4 2025, from $20.5 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $20.5 million in Q3 2025 to a low of $943344.0 in Q2 2021.
• A 5-year average of $3.5 million and a median of $2.2 million in 2021 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables slumped 59.81% in 2024 and jumped 1422.09% in 2025, its largest moves.
• Tracing CRMD's Accounts Payables over 5 years: stood at $2.2 million in 2021, then dropped by 0.34% to $2.2 million in 2022, then jumped by 94.34% to $4.3 million in 2023, then plunged by 59.81% to $1.7 million in 2024, then jumped by 358.37% to $7.9 million in 2025.
• Business Quant data shows CRMD's Accounts Payables at $7.9 million in Q4 2025, $20.5 million in Q3 2025, and $5.8 million in Q2 2025.